Gilder, Gagnon, Howe & Co »

Madrigal Pharmaceuticals shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $10M 39k 267.04

More positions owned by Gilder, Gagnon, Howe & Co

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Netflix (NFLX)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Cloudflare Cl A Com (NET)
Eli Lilly & Co. (LLY)
Freshpet (FRPT)
Duolingo Cl A Com (DUOL)
Intuitive Surgical Com New (ISRG)
Mongodb Cl A (MDB)
Shake Shack Cl A (SHAK)
Shockwave Med
Hubspot (HUBS)
Appfolio Com Cl A (APPF)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
Paulson & Co
Vanguard Group
BlackRock
T. Rowe Price Associates
State Street Corporation
Susquehanna International
Geode Capital Management
Artisan Partners Limited Partnership
Perceptive Advisors
Rock Springs Capital Management
Bank of America Corporation
Morgan Stanley
Goldman Sachs Group

View all funds holding Madrigal Pharmaceuticals